Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jasminum-based Nano-reinforced Calcium Hydroxide for Postoperative Pain in Necrotic Pulp
NCT06653608Completed
- Sponsor
- Pakistan Institute of Medical Sciences
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of jasminum + calcium hydroxide in dental pulp necrosis and apical periodontitis (AP) (2 arms), sponsored by Pakistan Institute of Medical Sciences. Primary endpoint: Post-operative pain at 96 hours. Started Apr 2024; status: completed.
02
Drugs
jasminum + calcium hydroxide
03
Conditions
dental pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT06653608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653608.